A5033869852- Urinary Bladder and Prostate Research
- Bee Products Chemical Analysis
- Prostate Cancer Treatment and Research
- Cancer, Lipids, and Metabolism
- Hormonal and reproductive studies
- Pelvic floor disorders treatments
- Brain Metastases and Treatment
- Cancer-related cognitive impairment studies
- Metabolism, Diabetes, and Cancer
- Sexual function and dysfunction studies
- Bladder and Urothelial Cancer Treatments
- Urologic and reproductive health conditions
- Urinary and Genital Oncology Studies
- Cancer survivorship and care
Kaohsiung Medical University
2017-2021
Kaohsiung Medical University Chung-Ho Memorial Hospital
2017-2021
Kaohsiung Municipal Hsiao-Kang Hospital
2021
Managing patients with chronic pelvic pain syndrome (CPPS) refractory to the traditional 3-As therapy (antibiotics, alpha-blockers, and anti-inflammatories) is a challenging task. Low-intensity extracorporeal shock wave (LI-ESWT) was recently reported be able improve pain, urinary symptoms, even sexual function by inducing neovascularization anti-inflammation, reducing muscle tone, influencing nerve impulses. This study evaluates whether combined treatment LI-ESWT can restore clinical...
Introduction: Androgen-deprivation therapy (ADT) is recognized to be the preferred first-line treatment for advanced prostate cancer. However, risk–benefit ratio of ADT remains poorly defined and relationship between androgen depletion dementia not clear.Aim: To investigate risk developing Alzheimer's disease (AD) in patients undergoing cancer.Methods: Data from 24 360 cancer were collected Longitudinal Health Insurance Database Taiwan. In total, 15 959 who underwent included study cohort,...
Applying low-intensity extracorporeal shockwave therapy (LI-ESWT) has been reported to improve symptoms of refractory chronic pelvic pain syndrome (CPPS) in short-term follow-up. This study aims demonstrate the effect LI-ESWT on CPPS over span a 12-month follow-up.This was an open-label, single-arm prospective study. consisted 3000 shock waves once weekly for 4 weeks (Duolith SD1 T-Top) were applied. Clinical re-assessed at 1, 3, 6, and 12 months using NIH-CPSI score, visual analog scale,...
Abstract IMT is a rare but sometimes life‐threatening tumor. Although presenting with muscle invasion, local surgical resection TURBT and close follow‐up are adequate bladder function life quality preservation compared to partial cystectomy.